Luffa Operculata
Generic Name: luffa operculata
Dosage form: LIQUID. Active ingredients: LUFFA OPERCULATA FRUIT (1 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: LUFFA OPERCULATA FRUIT (1 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Alafenamide
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
11 DESCRIPTION ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) is a fixed-dose combination tablet containing emtricitabine (FTC), rilpivirine (RPV), and tenofovir alafenamide (TAF) for oral administration. FTC, a synthetic nucleoside analog of cytidine, is an HIV-1 nucleoside analog reverse transcriptase inhibitor (HIV-1 NRTI). RPV is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).
Dextromethorphan Hydrobromide, Guaifenesin, Chlorpheniramine Maleate
dextromethorphan hydrobromide, guaifenesin, chlorpheniramine maleate
Purposes – Children’s Robitussin Cough & Chest Congestion DM Cough Suppressant Expectorant
Axicabtagene Ciloleucel
axicabtagene ciloleucel
CD19-directed Chimeric Antigen Receptor [EPC]
11 DESCRIPTION YESCARTA (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. To prepare YESCARTA, a patient's own T cells are harvested and genetically modified ex vivo by retroviral transduction to express a chimeric antigen receptor (CAR) comprising a murine anti-CD19 single chain variable fragment (scFv) linked to CD28 and CD3-zeta co-stimulatory domains.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.